The effects of newer antidepressants on low-density lipoprotein cholesterol levels.
Jean-Michel
JM
Le Mellédo
Maria
M
del Pilar Castillo Abadia
Steve
S
Newman
Darrin
D
Bailey
Ross
R
Tsuyuki
Gabor
G
Gyenes
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects*; D015986:Confounding Factors, Epidemiologic; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000139:chemically induced; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D000078785:Mirtazapine; D012107:Research Design / Q000592:standards; D015983:Selection Bias; D012737:Sex Factors
D000929:Antidepressive Agents, Tricyclic; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008803:Mianserin; D000078785:Mirtazapine